Symptom modifying effect of chondroitin sulfate

　The STOPP study(osteoarthritis progression prevention), a 2 year prospective study have demonstrated definite SYSADOA symptom modifying effect of chondroitin sulfate 800mg/day and structure modifying effect to a lesser degree SMOAD.  SO, may be we can continue with chondroitin sulfate  as a symptom modifying drug with no major side effects. its a good idea to check and monitor  blood glucose and  serum cholestrol during the first few months as there are some rare reports. May be a biochemical mri - sodium mri in a 7 T machine could enligthen us further